Dainippon Sumitomo Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

1,618JPY
9:05am IST
Price Change (% chg)

¥15 (+0.94%)
Prev Close
¥1,603
Open
¥1,611
Day's High
¥1,631
Day's Low
¥1,604
Volume
318,000
Avg. Vol
1,218,753
52-wk High
¥1,947
52-wk Low
¥1,172

4506.T

Chart for 4506.T

About

Dainippon Sumitomo Pharma Co.,Ltd. is a pharmaceutical company. The Japan division manufactures and sells ethical and general use drugs. The North America division manufactures, develops, purchases and sells ethical drugs through its consolidated subsidiaries. The China division manufactures and sells ethical drugs through its... (more)

Overall

Beta: 0.70
Market Cap (Mil.): ¥648,975.12
Shares Outstanding (Mil.): 397.90
Dividend: 9.00
Yield (%): 1.10

Financials

  4506.T Industry Sector
P/E (TTM): 52.54 33.36 33.52
EPS (TTM): 31.04 -- --
ROI: 2.45 19.69 18.94
ROE: 3.38 20.38 19.71
Search Stocks

Japan's Takeda, Dainippon get EU nod for schizophrenia drug

TOKYO, March 31 - Takeda Pharmaceutical Co Ltd and Dainippon Sumitomo Pharma Co Ltd said on Monday the European Commission had given them marketing authorisation for Latuda, a once-a-day oral treatment for schizophrenia in adults.

31 Mar 2014

U.S. FDA approves Sunovion Pharmaceuticals' seizure drug

- U.S. health regulators on Friday approved a new drug made by Sunovion Pharmaceuticals, a U.S.-based unit of Japanese drugmaker Dainippon Sumitomo Pharma Co, as an add-on medicine to reduce seizures associated with epilepsy.

09 Nov 2013

U.S. FDA approves Sunovion Pharmaceuticals' seizure drug

Nov 8 - U.S. health regulators on Friday approved a new drug made by Sunovion Pharmaceuticals, a U.S.-based unit of Japanese drugmaker Dainippon Sumitomo Pharma Co, as an add-on medicine to reduce seizures associated with epilepsy.

09 Nov 2013

Earnings vs. Estimates

Search Stocks